Document Detail


Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30).
MedLine Citation:
PMID:  2460148     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Human seminal vesicle and prostatic fluids were obtained separately and reconstituted in vitro to test the hypothesis that proteolytic enzymes of prostatic origin would degrade seminal vesicle-specific antigen (SVSA). Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analysis to follow the fate of SVSA over time, we found that upon mixing the two secretions, SVSA was converted to forms of intermediate and low molecular weight identical to transformations seen in normal liquefied ejaculates. Diisoproprylfluorophophate, a serine protease inhibitor, prevented this degradation, indicating serine protease involvement in the proteolysis of SVSA. Prostate-specific antigen (PSA; also known as P-30), recently identified as a serine protease, was examined for its ability to mimic the effects of prostatic fluid on SVSA. Purified PSA catalyzed degradation of SVSA to produce proteolytic fragments that comigrated and were immunologically related to SVSA fragments produced by prostatic fluid. Purified PSA in the presence of serine protease inhibitors was unable to degrade SVSA. These results demonstrate that SVSA is a substrate for PSA during human semen liquefaction.
Authors:
R S McGee; J C Herr
Related Documents :
1725158 - Metastatic prostatic adenocarcinoma-diagnosed by bronchoalveolar lavage and tumour mark...
10197848 - Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free ...
18549428 - Highly specific detection of prostate-specific antigen-positive cells in the blood of p...
16192588 - Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence...
19487288 - Expression of the k303r estrogen receptor-alpha breast cancer mutation induces resistan...
3409168 - Plasma tetranectin is reduced in cancer and related to metastasia.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biology of reproduction     Volume:  39     ISSN:  0006-3363     ISO Abbreviation:  Biol. Reprod.     Publication Date:  1988 Sep 
Date Detail:
Created Date:  1988-12-12     Completed Date:  1988-12-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0207224     Medline TA:  Biol Reprod     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  499-510     Citation Subset:  IM    
Affiliation:
Department of Anatomy and Cell Biology, University of Virginia Medical Center, Charlottesville 22908.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, Neoplasm / immunology*
Blotting, Western
Body Fluids / analysis
Electrophoresis, Polyacrylamide Gel
Humans
Isoflurophate / pharmacology
Male
Molecular Weight
Peptide Hydrolases / metabolism
Phenylmethylsulfonyl Fluoride / pharmacology
Prostate-Specific Antigen
Semen / analysis
Seminal Vesicles / immunology*
Grant Support
ID/Acronym/Agency:
HD 16767/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, Neoplasm; 329-98-6/Phenylmethylsulfonyl Fluoride; 55-91-4/Isoflurophate; EC 3.4.-/Peptide Hydrolases; EC 3.4.21.77/Prostate-Specific Antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro effects of pregnancy-associated plasma protein-A: artifacts due to heparin.
Next Document:  Chemotactic activity of recombinant human granulocyte colony-stimulating factor.